Brensocatib Significantly Lowers Flare Risk in Non-CF Bronchiectasis, Trial Shows
News
Treatment with brensocatib significantly and safely extended the time to a first exacerbation and lowered flare rates in people with non-cystic fibrosis bronchiectasis (NCFBE), results from a Phase 2 trial show. ... Read more